Literature DB >> 995788

Anti-inflammatory action of corticosteroids.

M W Greaves.   

Abstract

The anti-inflammatory action of corticosteroids is complex. At a cellular level, they cause redistribution of granulocytes, resulting in increased circulating granulocytes and reduced tissue pools. They also cause lymphopenia. The significance of these phenomena in relation to the anti-inflammatory activity of steroids is unknown. The most obvious pharmacological effects of corticosteroids are seen on blood vessels. They cause adrenergically mediated vasoconstriction and non-competitive antagonism of vasodilation due to prostaglanin E and bradykinin. Prostaglandin formation is inhibited by corticosteroids but whether this is due to an effect on enzymic synthesis or release is uncertain. Corticosteroids stabilize the lysosomal membrane preventing release of lysosomal enzymes in vitro but the significance of this in vivo is debatable.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 995788      PMCID: PMC2496363          DOI: 10.1136/pgmj.52.612.631

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  12 in total

1.  Corticosteroids inhibit prostaglandin production by rheumatiod synovia.

Authors:  F Kantrowitz; D R Robinson; M B McGuire; L Levine
Journal:  Nature       Date:  1975-12-25       Impact factor: 49.962

2.  Chemical and biological factors in the activity of adrenocortical steroids.

Authors:  I E BUSH
Journal:  Pharmacol Rev       Date:  1962-09       Impact factor: 25.468

3.  STUDIES IN THE MECHANISM OF STEROID VASOCONSTRICTION.

Authors:  L M SOLOMON; H E WENTZEL; M S GREENBERG
Journal:  J Invest Dermatol       Date:  1965-02       Impact factor: 8.551

4.  Inhibition of release of prostaglandins as an explanation of some of the actions of anti-inflammatory corticosteroids.

Authors:  G P Lewis; P J Piper
Journal:  Nature       Date:  1975-03-27       Impact factor: 49.962

5.  Prostaglandins, aspirin-like drugs and the oedema of inflammation.

Authors:  S Moncada; S H Ferreira; J R Vane
Journal:  Nature       Date:  1973-11-23       Impact factor: 49.962

6.  Corticosteroid administration and localized leukocyte mobilization in man.

Authors:  W P Peters; J F Holland; H Senn; W Rhomberg; T Banerjee
Journal:  N Engl J Med       Date:  1972-02-17       Impact factor: 91.245

7.  The effects of a series of prostaglandins on in vitro models of the allergic response and cellular immunity.

Authors:  L M Lichtenstein; E Gillespie; H R Bourne; C S Henney
Journal:  Prostaglandins       Date:  1972-12

8.  Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs.

Authors:  J R Vane
Journal:  Nat New Biol       Date:  1971-06-23

9.  Interaction between prostaglandins E and F given intradermally in the rat.

Authors:  P Crunkhorn; A L Willis
Journal:  Br J Pharmacol       Date:  1971-03       Impact factor: 8.739

10.  Prostaglandin biosynthesis by human skin and its inhibition by corticosteroids.

Authors:  M W Greaves; W McDonald-Gibson
Journal:  Br J Pharmacol       Date:  1972-09       Impact factor: 8.739

View more
  15 in total

1.  Perioperative use of an anti-inflammatory drug on tooth sensitivity caused by in-office bleaching: a randomized, triple-blind clinical trial.

Authors:  Eloisa Andrade de Paula; Alessandro D Loguercio; Daniel Fernandes; Stella Kossatz; Alessandra Reis
Journal:  Clin Oral Investig       Date:  2013-01-31       Impact factor: 3.573

2.  Evaluation of positive and negative predictors of seizure outcomes among patients with immune-mediated epilepsy: a meta-analysis.

Authors:  Divyanshu Dubey; Zehra Farzal; Ryan Hays; L Steven Brown; Steven Vernino
Journal:  Ther Adv Neurol Disord       Date:  2016-07-04       Impact factor: 6.570

3.  Toxic megacolon from fulminant Clostridium difficile infection induced by topical silver sulphadiazine.

Authors:  Christopher B Tan; Dhyan Rajan; Mitanshu Shah; Shadab Ahmed; Lester Freedman; Kaleem Rizvon; Paul Mustacchia
Journal:  BMJ Case Rep       Date:  2012-08-08

4.  Chronic preoperative corticosteroid use is not associated with surgical site infection following revision total knee arthroplasty.

Authors:  Safa C Fassihi; Alex Gu; Dana A Perim; Chapman Wei; Seth Stake; Savyasachi Thakkar; Anthony S Unger; Michael P Ast; Peter K Sculco
Journal:  J Orthop       Date:  2020-01-28

Review 5.  New Insights into the Immune Molecular Regulation of the Pathogenesis of Acute Respiratory Distress Syndrome.

Authors:  Chin-Yao Yang; Chien-Sheng Chen; Giou-Teng Yiang; Yeung-Leung Cheng; Su-Boon Yong; Meng-Yu Wu; Chia-Jung Li
Journal:  Int J Mol Sci       Date:  2018-02-16       Impact factor: 5.923

6.  Pro-resolving mediators promote resolution in a human skin model of UV-killed Escherichia coli-driven acute inflammation.

Authors:  Madhur P Motwani; Romain A Colas; Marc J George; Julia D Flint; Jesmond Dalli; Angela Richard-Loendt; Roel Ph De Maeyer; Charles N Serhan; Derek W Gilroy
Journal:  JCI Insight       Date:  2018-03-22

7.  The Effects of Chronic Preoperative Steroid Therapy on Perioperative Complications Following Elective Posterior Lumbar Fusion.

Authors:  William A Ranson; Samuel J W White; Zoe B Cheung; Christopher Mikhail; Ivan Ye; Jun S Kim; Samuel K Cho
Journal:  Global Spine J       Date:  2018-05-10

8.  Potent Anti-Inflammatory and Pro-Resolving Effects of Anabasum in a Human Model of Self-Resolving Acute Inflammation.

Authors:  Madhur P Motwani; Frances Bennett; Paul C Norris; Alexander A Maini; Marc J George; Justine Newson; Alice Henderson; Adrian J Hobbs; Mark Tepper; Barbara White; Charles N Serhan; Raymond MacAllister; Derek W Gilroy
Journal:  Clin Pharmacol Ther       Date:  2018-01-30       Impact factor: 6.875

Review 9.  The Emerging Role of Pathogenesis of IgA Nephropathy.

Authors:  Meng-Yu Wu; Chien-Sheng Chen; Giou-Teng Yiang; Pei-Wen Cheng; Yu-Long Chen; Hsiao-Chen Chiu; Kuan-Hung Liu; Wen-Chin Lee; Chia-Jung Li
Journal:  J Clin Med       Date:  2018-08-20       Impact factor: 4.241

10.  Systemic interventions for severe atopic and vernal keratoconjunctivitis in children and young people up to the age of 16 years.

Authors:  Soyang Ella Kim; Victoria Nowak; Ana Quartilho; Frank Larkin; Melanie Hingorani; Stephen Tuft; Annegret Dahlmann-Noor
Journal:  Cochrane Database Syst Rev       Date:  2020-10-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.